“`html
BOSTON, November 15, 2023 – women with metabolic syndrome during pregnancy may have altered placental development, potentially impacting fetal health, a new study reveals. Researchers found important differences in placental structure between mothers with and without the condition, raising concerns about long-term consequences for both mother and child.
Placental Changes Linked to Maternal Metabolic Health
Table of Contents
A comparative study highlights structural differences in placentas of women with metabolic syndrome.
- Maternal metabolic syndrome-a cluster of conditions including high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal fat-is increasingly common during pregnancy.
- The study, conducted between January 2021 and December 2022, compared placental gross morphology in 60 women with metabolic syndrome to 60 healthy pregnant women.
- Researchers observed statistically significant differences in placental weight, length, width, and thickness between the two groups.
- These structural alterations could potentially affect placental function, impacting nutrient and oxygen delivery to the fetus.
Understanding the impact of maternal metabolic syndrome on placental development is crucial, as the placenta is the lifeline between mother and baby. This research provides a detailed look at how this common condition affects this vital organ.
What is Metabolic Syndrome and Why Does it Matter in Pregnancy?
Metabolic syndrome isn’t a single disease, but a collection of risk factors that increase the likelihood of heart disease, stroke, and type 2 diabetes. During pregnancy, these factors can become even more problematic. the study defined metabolic syndrome based on the International Diabetes Federation criteria, requiring the presence of central obesity plus any two of the following: raised triglycerides, reduced HDL cholesterol, raised blood pressure, or raised fasting plasma glucose.
A: The study found that women with metabolic syndrome had placentas that were, on average, heavier but also exhibited alterations in length, width, and thickness compared to those without the condition, suggesting a disruption in normal placental development.
study Details
The research, spanning from January 2021 to December 2022, involved a comparative analysis of placental gross morphology in 60 women diagnosed with metabolic syndrome and a control group
